Larimar Therapeutics, Inc. (LRMR) Earnings
|
Expand Research on LRMR
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -2.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -6.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/18/26  |
Q425 | N/A | -$0.49 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/5/25 |
Q325 | N/A | -$0.41 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/14/25 | Q225 | -$0.41 | -$0.48 | +$0.07 | N/A | N/A | N/A |  | | Details | |
| 8/11/25 |
Q225 | N/A | -$0.48 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/7/25 |
Q225 | N/A | -$0.48 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/8/25 |
Q125 | N/A | -$0.35 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/24/25 | Q424 | -$0.45 | -$0.31 | -$0.14 | N/A | N/A | N/A | | | Details | |
| 3/21/25 |
Q424 | N/A | -$0.31 | N/A | N/A | N/A | N/A | N/A | N/A |
